124 related articles for article (PubMed ID: 1765863)
21. Value of beryllium lymphocyte transformation tests in chronic beryllium disease and in potentially exposed workers.
Williams WJ; Williams WR
Thorax; 1983 Jan; 38(1):41-4. PubMed ID: 6845261
[TBL] [Abstract][Full Text] [Related]
22. Use of the Beryllium Lymphocyte Proliferation Test (BeLPT) for screening.
Lebeau J
J Occup Environ Med; 2007 Apr; 49(4):357-8; author reply 358-9. PubMed ID: 17426515
[No Abstract] [Full Text] [Related]
23. Beryllium-ferritin: lymphocyte proliferation and macrophage apoptosis in chronic beryllium disease.
Sawyer RT; Day BJ; Fadok VA; Chiarappa-Zucca M; Maier LA; Fontenot AP; Silveira L; Newman LS
Am J Respir Cell Mol Biol; 2004 Oct; 31(4):470-7. PubMed ID: 15256386
[TBL] [Abstract][Full Text] [Related]
24. Prevention of beryllium sensitization and chronic beryllium disease.
Henneberger PK; Goe SK; Miller WE; Doney B; Groce DW
J Occup Environ Hyg; 2006 Apr; 3(4):D42-3. PubMed ID: 16507518
[No Abstract] [Full Text] [Related]
25. Use of proliferation tests to evaluate the effects of complexing agents on beryllium toxicity.
Stephan CH; Sauvé S; Fournier M; Brousseau P
J Appl Toxicol; 2009 Jan; 29(1):27-35. PubMed ID: 18785683
[TBL] [Abstract][Full Text] [Related]
26. A canine model of beryllium-induced granulomatous lung disease.
Haley PJ; Finch GL; Mewhinney JA; Harmsen AG; Hahn FF; Hoover MD; Muggenburg BA; Bice DE
Lab Invest; 1989 Aug; 61(2):219-27. PubMed ID: 2755079
[TBL] [Abstract][Full Text] [Related]
27. Beryllium hypersensitivity and chronic beryllium lung disease.
Santo Tomas LH
Curr Opin Pulm Med; 2009 Mar; 15(2):165-9. PubMed ID: 19532033
[TBL] [Abstract][Full Text] [Related]
28. [State of the peripheral blood in persons working in contact with beryllium and in berylliosis patients].
Ivanova LA; Nikitina LS; Vasil'eva NS; Sokolov VV
Gig Tr Prof Zabol; 1980 Nov; (11):19-23. PubMed ID: 7439743
[No Abstract] [Full Text] [Related]
29. Beryllium Biobank 3: considerations for improving chronic beryllium disease screening.
Harber P; Su J
J Occup Environ Med; 2014 Aug; 56(8):861-6. PubMed ID: 25099414
[TBL] [Abstract][Full Text] [Related]
30. [Beryllium--underestimated occupational health hazard in Poland].
Dudek W; Walusiak J; Wittczak T
Med Pr; 2001; 52(6):471-8. PubMed ID: 11928678
[TBL] [Abstract][Full Text] [Related]
31. Systematic review: Progression of beryllium sensitization to chronic beryllium disease.
Seidler A; Euler U; Müller-Quernheim J; Gaede KI; Latza U; Groneberg D; Letzel S
Occup Med (Lond); 2012 Oct; 62(7):506-13. PubMed ID: 22705916
[TBL] [Abstract][Full Text] [Related]
32. Racial differences in prevalence of a supratypic HLA-genetic marker immaterial to pre-employment testing for susceptibility to chronic beryllium disease.
Weston A; Ensey J; Kreiss K; Keshava C; McCanlies E
Am J Ind Med; 2002 Jun; 41(6):457-65. PubMed ID: 12173370
[TBL] [Abstract][Full Text] [Related]
33. The beryllium lymphocyte proliferation test: Relevant issues in beryllium health surveillance.
Stange AW; Furman FJ; Hilmas DE
Am J Ind Med; 2004 Nov; 46(5):453-62. PubMed ID: 15490468
[TBL] [Abstract][Full Text] [Related]
34. Ultrafine beryllium number concentration as a possible metric for chronic beryllium disease risk.
McCawley MA; Kent MS; Berakis MT
Appl Occup Environ Hyg; 2001 May; 16(5):631-8. PubMed ID: 11370941
[TBL] [Abstract][Full Text] [Related]
35. Introduction to the conference on beryllium-related diseases.
Jameson CW
Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):935-6. PubMed ID: 8933037
[No Abstract] [Full Text] [Related]
36. Enhanced preventive programme at a beryllium oxide ceramics facility reduces beryllium sensitisation among new workers.
Cummings KJ; Deubner DC; Day GA; Henneberger PK; Kitt MM; Kent MS; Kreiss K; Schuler CR
Occup Environ Med; 2007 Feb; 64(2):134-40. PubMed ID: 17043076
[TBL] [Abstract][Full Text] [Related]
37. A study on the beryllium lymphocyte transformation test and the beryllium levels in working environment.
Yoshida T; Shima S; Nagaoka K; Taniwaki H; Wada A; Kurita H; Morita K
Ind Health; 1997 Jul; 35(3):374-9. PubMed ID: 9248221
[TBL] [Abstract][Full Text] [Related]
38. Role of the berylliosis-associated HLA-DPGlu69 supratypic variant in determining the response to beryllium in a blood T-cells beryllium-stimulated proliferation test.
Amicosante M; Deubner D; Saltini C
Sarcoidosis Vasc Diffuse Lung Dis; 2005 Oct; 22(3):175-9. PubMed ID: 16315779
[TBL] [Abstract][Full Text] [Related]
39. Serum neopterin in chronic beryllium disease.
Harris J; Bartelson BB; Barker E; Balkissoon R; Kreiss K; Newman LS
Am J Ind Med; 1997 Jul; 32(1):21-6. PubMed ID: 9131208
[TBL] [Abstract][Full Text] [Related]
40. Beryllium induces IL-2 and IFN-gamma in berylliosis.
Tinkle SS; Kittle LA; Schumacher BA; Newman LS
J Immunol; 1997 Jan; 158(1):518-26. PubMed ID: 8977230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
